Tag:
Endosense
Latest Headlines
Latest Headlines
Endosense eyes FDA nod with ablation trial
Fresh off raising $40.3 million in venture cash, Endosense has treated its first American patient in a study of its cardiac catheter ablation device, and the company is amassing data to support an FDA application.
Endosense's cardiac catheter ablation tech lures $40.3M Series C
Endosense attracted $40.3 million in new Series C financing that demonstrates the increasing interest in catheter ablation to treat cardiac arrhythmias. The Swiss devicemaker already has several products in the space that are on sale or under development, and the new cash infusion will help move along U.S. regulatory efforts and grow its European sales force.
Keltjens tapped as Endosense president, CEO
Switzerland's Endosense has named Jan Keltjens as president and CEO. He replaces Eric Le Royer, who is retiring from Endosense after leading the firm from its first venture capital financing 7 years
